These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 5468601)
1. The assessment and treatment of endocrine exophthalmos. Cant JS Proc R Soc Med; 1970 Aug; 63(8):783-6. PubMed ID: 5468601 [No Abstract] [Full Text] [Related]
2. [Basedow's disease with malignant exophthalmos treated with radioactive total thyroidectomy]. Stancu H; Bălan M Stud Cercet Endocrinol; 1973; 24(3):231-3. PubMed ID: 4739974 [No Abstract] [Full Text] [Related]
3. [Internal (medical) and surgical treatment of endocrine exophthalmos]. Boerema I; Stortenbeek W Ned Tijdschr Geneeskd; 1970 Feb; 114(9):361-8. PubMed ID: 5467077 [No Abstract] [Full Text] [Related]
4. [Treatment of the malignant phase of infiltrative-edematous exophthalmos in Graves-Basedow disease]. Zgliczyński S; Górowski T; Jastrzebska H; Janik J; Machnicka J; Ulkowski M; Kuś J; Bonisławski D Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):981-6. PubMed ID: 6548809 [No Abstract] [Full Text] [Related]
5. Observations on the therapeutic merit of thyroid radioablation for treatment of malignant exophthalmos. Weiss ER; Blahd WH; Winston MA; Krishnamurthy GT Nucl Med (Stuttg); 1972 Nov; 11(3):226-33. PubMed ID: 4678769 [No Abstract] [Full Text] [Related]
6. [Treatment of endocrine ophthalmopathy]. Raith L Z Allgemeinmed; 1973 Dec; 49(35):1727-30. PubMed ID: 4131142 [No Abstract] [Full Text] [Related]
7. [The value of tonometry in differential diagnosis of malignant exophthalmos]. Strazhdina TD Vestn Oftalmol; 1968; 81(1):54-7. PubMed ID: 5757471 [No Abstract] [Full Text] [Related]
8. [On the pathogenetic significance of hypophyseal factors in endocrine ophthalmopathy]. Mertz DP; Stelzer M Dtsch Med Wochenschr; 1969 Jan; 94(1):27-32. PubMed ID: 5818126 [No Abstract] [Full Text] [Related]
9. Management of the active severe eye changes of Graves' disease. Werner SC Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401 [No Abstract] [Full Text] [Related]
10. [The treatment of malignant exophthalmos by means of total thyroidectomy]. Müller W; Schemmel K; Uthgenannt H; Weissbecker L Dtsch Med Wochenschr; 1967 Nov; 92(46):2103-6. PubMed ID: 5630417 [No Abstract] [Full Text] [Related]
11. Ophthalmopathy of Graves' disease: a comparison between patients treated surgically and patients treated with radioiodide. Hamilton RD; Mayberry WE; McConahey WM; Hanson KC Mayo Clin Proc; 1967 Dec; 42(12):812-8. PubMed ID: 5630560 [No Abstract] [Full Text] [Related]
12. Malignant exophthalmos. Zellmann HE Med Clin North Am; 1969 Mar; 53(2):469-77. PubMed ID: 5818921 [No Abstract] [Full Text] [Related]
13. [Present status of treatment of Basedow's disease (including exophthalmos)]. Tamai H Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1142-6. PubMed ID: 9379090 [No Abstract] [Full Text] [Related]
15. Attempt at thyroid ablation with radioactive iodine for the treatment of ophthalmopathy in Graves' disease. Fawell WN; Catz B Am J Med Sci; 1973 Jun; 265(6):467-72. PubMed ID: 4740469 [No Abstract] [Full Text] [Related]
16. [New radiotherapy procedure for the treatment of endocrine exophthalmos]. Petrányi G; Fazakas S; Gát G Endokrinologie; 1964; 46(5):285-8. PubMed ID: 5339902 [No Abstract] [Full Text] [Related]
17. Graves' ophthalmopathy: medical management. el Sheikh M; McGregor AM Curr Ther Endocrinol Metab; 1997; 6():90-4. PubMed ID: 9174711 [No Abstract] [Full Text] [Related]
18. [Current therapeutic attitude toward endocrine exophthalmos]. Trottier M Union Med Can; 1966 Nov; 95(11):1289-90. PubMed ID: 4167016 [No Abstract] [Full Text] [Related]